Bone Marrow News and Research

RSS

Bone Marrow is the soft, sponge-like tissue in the center of most bones. It produces white blood cells, red blood cells, and platelets.

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Acute T-cell lymphoblastic leukemia is a rare type of blood cancer that affects mostly children. This blood cancer appears from the precursor cells that produce T lymphocytes.

28 Jan 2019

Scientists discover new blood vessels in bone

Researchers have discovered new blood vessels in the long bones of mice and similar new vessels in human long bones that could be used to further our understanding of osteoporosis.

23 Jan 2019

Researchers gain new insights into development of necrotizing enterocolitis in preemies

Researchers at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues, discovered a promising direction toward understanding the development of necrotizing enterocolitis, a devastating intestinal disease commonly affecting premature infants, in order to treat it.

23 Jan 2019

TPU scientists develop new implants that double the rate of bone lengthening in kids

The implants developed by TPU scientists passed preclinical trials In the Ilizarov Orthopedic Center. These implants form part of the Ilizarov system variation applied for lengthening and correcting the deformations of long tubular bones in children.

22 Jan 2019

Researchers discover new blood vessel system in bones

Bones are very hard organs. Still they do possess a tight meshwork of blood vessels in their inner cavity, where the bone marrow is located, as well as on the bone surface, that is covered by the highly vascularized periosteum.

21 Jan 2019

FSU study provides better understanding of spinal cord injuries

Thousands of people worldwide suffer severe spinal cord injuries each year, but little is known about why these injuries often continue to deteriorate long after the initial damage occurs.

21 Jan 2019

Study to investigate new targeted oral treatments for severe asthma

A £2.68 million study to investigate the effective use of antibiotics to treat certain types of severe asthma is being spearheaded by researchers in Leicester.

21 Jan 2019

Mount Sinai joins with Paradigm and ReqMed to repurpose drug for treatment of MPS

The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for and ReqMed Company, Ltd. of Japan.

21 Jan 2019

Many cancer patients have undiagnosed hepatitis

A new report has described an alarmingly high rate of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer.

17 Jan 2019

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Beckman Coulter launches the ClearLLab 10C System - the first 10-colour CE-IVD panels of immunophenotyping reagents for lymphoid and myeloid lineages.

From Beckman Coulter Life Sciences - Flow Cytometry 17 Jan 2019

Yeast model may pave way for development of novel therapies for metabolic disorders

There are hundreds of metabolic disorders -- including phenylketonuria, tyrosinemia, maple syrup urine disease and homocystinuria.

17 Jan 2019

Study determines impact of antibiotic perturbation of the gut microbiome on skeletal health

Microbes are often seen as pathogens that cause disease and antibiotics have been used successfully to combat these foreign invaders. In reality, the picture is more complex.

17 Jan 2019

New method modifies blood stem cells to reverse genetic mutation that causes IPEX

UCLA researchers led by Dr. Donald Kohn have created a method for modifying blood stem cells to reverse the genetic mutation that causes a life-threatening autoimmune syndrome called IPEX.

11 Jan 2019

Research provides clues for understanding and optimizing bone marrow transplants

Bone marrow transplants, which involve transplanting healthy blood stem cells, offer the best treatment for many types of cancers, blood disorders and immune diseases. Even though 22,000 of these procedures are performed each year in the US, much remains to be understood about how they work.

9 Jan 2019

Health care industry spends $30b a year pushing its wares, from drugs to stem cell treatment

Hoping to earn its share of the $3.5 trillion health care market, the medical industry is pouring more money than ever into advertising its products — from high-priced prescriptions to do-it-yourself genetic tests and unapproved stem cell treatments.

8 Jan 2019

Scientists discover two therapies that slow progression of pediatric leukemia in mice

Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes & Development.

24 Dec 2018

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report published online today in Blood. Lung and colon cancers, as well as advanced-staged cancers, appear to be most strongly associated with an elevated risk of heart attack and stroke caused by blood clots in the arteries.

24 Dec 2018

FDA approves new treatment for rare disease of the bone marrow and blood

The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.

21 Dec 2018

CHLA researcher reveals how leukemia burrows within the bone marrow

Actually, cancer can hide. A researcher at Children's Hospital Los Angeles tells us exactly how leukemia burrows within bone marrow, where it is shielded from chemotherapy treatments.

21 Dec 2018

Active ingredient in eye drops shows promise for treating aggressive blood cancer

An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.

19 Dec 2018

Bone Marrow News and Research

Further Reading

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Scientists discover new blood vessels in bone

Researchers gain new insights into development of necrotizing enterocolitis in preemies

TPU scientists develop new implants that double the rate of bone lengthening in kids

Researchers discover new blood vessel system in bones

FSU study provides better understanding of spinal cord injuries

Study to investigate new targeted oral treatments for severe asthma

Mount Sinai joins with Paradigm and ReqMed to repurpose drug for treatment of MPS

Many cancer patients have undiagnosed hepatitis

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Yeast model may pave way for development of novel therapies for metabolic disorders

Study determines impact of antibiotic perturbation of the gut microbiome on skeletal health

New method modifies blood stem cells to reverse genetic mutation that causes IPEX

Research provides clues for understanding and optimizing bone marrow transplants

Health care industry spends $30b a year pushing its wares, from drugs to stem cell treatment

Scientists discover two therapies that slow progression of pediatric leukemia in mice

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

FDA approves new treatment for rare disease of the bone marrow and blood

CHLA researcher reveals how leukemia burrows within the bone marrow

Active ingredient in eye drops shows promise for treating aggressive blood cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News